# Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

> **NCT01348256** · PHASE2 · UNKNOWN · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 58 (estimated)

## Conditions studied

- Colorectal Carcinoma
- Hepatic Metastasis

## Interventions

- **DRUG:** Dendritic cells vaccine

## Key facts

- **NCT ID:** NCT01348256
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2017-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348256, "Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01348256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*